IDenta Corp. (IDTA)
OTCMKTS
· Delayed Price · Currency is USD
0.180
-0.006 (-3.23%)
Mar 9, 2026, 9:50 AM EST
IDenta Revenue
IDenta had revenue of $427.52K in the quarter ending September 30, 2025, with 18.43% growth. This brings the company's revenue in the last twelve months to $1.24M, down -15.54% year-over-year. In the year 2024, IDenta had annual revenue of $1.46M with 38.41% growth.
Revenue (ttm)
1.24M
Revenue Growth
-15.54%
P/S Ratio
0.61
Revenue / Employee
88.82K
Employees
16
Market Cap
752.52K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.46M | 403.90K | 38.41% |
| Dec 31, 2023 | 1.05M | -287.16K | -21.45% |
| Dec 31, 2022 | 1.34M | -53.38K | -3.83% |
| Dec 31, 2021 | 1.39M | -57.76K | -3.98% |
| Dec 31, 2020 | 1.45M | 437.08K | 43.15% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2003 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ProPhase Labs | 5.06M |
| NovelStem International | 3.00K |
| InVitro International | 811.29K |
| T2 Biosystems | 7.68M |
| Centogene | 53.65M |
| Medical Imaging | 7.52M |
| Psychemedics | 19.69M |
| Aspira Women's Health | 9.34M |